Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 5/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.36 |
| ▸ | PNMT | P11086 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10192373 | 0.84 | HRH4 (0.39) | HRH4PTGS2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL26812067 | 0.76 | LMNA (0.43) | HRH4PTGS2AKR1C3AKR1C2HSP90AA1 | |
| SCHEMBL20526574 | 0.76 | G6PD (0.51) | HRH4PTGS2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL16960235 | 0.73 | TRPA1 (0.48) | SLC6A2 | |
| SCHEMBL12695017 | 0.73 | ALDH1A1 (0.47) | PTGS2AKR1C3AKR1C2HSP90AA1 | |
| SCHEMBL30526691 | 0.72 | SLC6A2 (0.49) | HRH4PTGS2SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL21756929 | 0.72 | GABRA1 (0.36) | SLC6A2 | |
| SCHEMBL1368631 | 0.72 | AKR1C3 (0.39) | HRH4PTGS2AKR1C3AKR1C2HSP90AA1 | |
| SCHEMBL1369917 | 0.72 | G6PD (0.50) | HRH4AKR1C3AKR1C2HSP90AA1 | |
| SCHEMBL16960232 | 0.72 | TRPA1 (0.31) | SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8674095-B2 | Compounds for treating neuropsychiatric conditions | AFRAXIS HOLDINGS, INC. (US) | 2014-03-18 | — | — | US | disclosed |